Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

98°
- Poteau, OK (74953)
  Today
  
  A stray shower or thunderstorm is possible early. Mostly clear. Low 73F. Winds light and variable..
  
  Tonight
  
  A stray shower or thunderstorm is possible early. Mostly clear. Low 73F. Winds light and variable.
  
  Updated: September 17, 2026 @ 5:28 pm
- Full Forecast

Site search

Home
News
Sports
Obituaries
Photos
PDN E-Edition
Classifieds
- Place an ad
Antlers American E-Edition
Archives
Best of 2026

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Zura Bio Limited - Class A Ordinary shares (NQ:ZURA)

4.165 +0.355 (+9.32%)

Delayed Quote Updated: 11:22 AM EDT, Oct 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Zura Bio Limited - Class A Ordinary shares

< Previous 1 2 3 Next >

These stocks have an unusual volume in today's session ↗

October 14, 2026

Via Chartmill

Analyst Sees Multi-Billion-Dollar Sales Potential for Zura Bio’s Lead Therapy ↗

July 08, 2026

William Blair starts Zura Bio (NASDAQ: ZURA) at Outperform, citing tibulizumab's multibillion-dollar potential in autoimmune disease.

Via Benzinga

ZURA BIO LTD (NASDAQ:ZURA) Q1 2026: Cash Runway Extended Through 2028 as Phase 2 Trials Advance ↗

May 07, 2026

Via Chartmill

Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million ↗

February 25, 2026

This biotech specializes in monoclonal antibody therapies for inflammatory and immunological diseases with significant unmet needs.

Via The Motley Fool

Topics Regulatory Compliance

This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges ↗

February 25, 2026

RAPT Therapeutics develops oral therapies for oncology and inflammatory diseases, with lead candidates progressing in clinical trials.

Via The Motley Fool

Topics Regulatory Compliance

ZURA Stock Earnings: Zura Bio Beats EPS for Q2 2024 ↗

May 09, 2024

ZURA stock results show that Zura Bio beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Where Zura Bio Stands With Analysts ↗

August 15, 2023

Via Benzinga

Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst ↗

February 25, 2026

This clinical-stage biotech develops therapies targeting hematologic disorders, with a pipeline centered on red blood cell biology.

Via The Motley Fool

Topics Regulatory Compliance

Unusual volume stocks are being observed in Wednesday's session. ↗

October 01, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Here are the top movers in Tuesday's session. ↗

September 30, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 30, 2025

Via Benzinga

These stocks are moving in today's session ↗

September 30, 2025

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 29, 2025

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44....

Via Benzinga

Top stock movements in today's session. ↗

September 29, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

September 29, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 29, 2025

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.

Via Benzinga

Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗

September 29, 2025

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its...

Via Benzinga

Novartis Drug Shows Improvement In Sjögren's Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As Well ↗

August 11, 2025

Novartis now sees the potential for the drug to become the first and only targeted treatment approved for patients with the disease.

Via Stocktwits

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 17, 2025

Via Benzinga

ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024 ↗

August 13, 2024

ZURA stock results show that Zura Bio missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

3 Undervalued Biotech Stocks With Breakout Potential ↗

July 19, 2024

Invest in these three undervalued biotech stocks with double-digit upside ahead driven by cutting-edge healthcare advancements

Via InvestorPlace

The 3 Most Undervalued Biotech Stocks to Buy in July 2024 ↗

July 12, 2024

There’s always a strong case for undervalued biotech stocks especially with newer innovation and demand for better treatment.

Via InvestorPlace

3 Penny Stocks to Buy Now: May 2024 ↗

May 24, 2024

Penny stocks to buy carry a considerable amount of risk and extra sue dilligence is required before buying shares.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 26, 2024

Via Benzinga

ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023 ↗

March 28, 2024

ZURA stock results show that Zura Bio missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 18, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023 ↗

October 10, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023 ↗

August 25, 2023

Via Benzinga

BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday ↗

June 29, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Poteau Daily News

PoteauDailyNews.com
804 N. Broadway
Poteau, OK 74953
Phone: 918-647-3188
Email: circulation@poteaudailynews.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Poteau, OK (74953)

Today

Tonight

Zura Bio Limited - Class A Ordinary shares (NQ:ZURA)

Headline News about Zura Bio Limited - Class A Ordinary shares

Sections

Services

Poteau Daily News